THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 20 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,207,000 | -54.6% | 2,500,000 | -50.0% | 0.01% | -58.8% |
| Q2 2020 | $4,859,000 | -0.4% | 5,000,000 | 0.0% | 0.03% | -10.5% |
| Q1 2020 | $4,879,000 | -6.3% | 5,000,000 | 0.0% | 0.04% | +46.2% |
| Q4 2019 | $5,205,000 | +12.5% | 5,000,000 | 0.0% | 0.03% | +4.0% |
| Q3 2019 | $4,628,000 | +6.7% | 5,000,000 | 0.0% | 0.02% | +4.2% |
| Q2 2019 | $4,337,000 | -10.7% | 5,000,000 | 0.0% | 0.02% | -20.0% |
| Q1 2019 | $4,855,000 | -5.9% | 5,000,000 | 0.0% | 0.03% | -11.8% |
| Q4 2018 | $5,157,000 | -13.6% | 5,000,000 | 0.0% | 0.03% | +3.0% |
| Q3 2018 | $5,972,000 | +20.3% | 5,000,000 | 0.0% | 0.03% | +10.0% |
| Q2 2018 | $4,966,000 | – | 5,000,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 25,388 | $23,544,000 | 2.40% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,675,000 | $46,013,000 | 1.22% |
| DeepCurrents Investment Group LLC | 33,824,000 | $31,165,000 | 0.93% |
| Aequim Alternative Investments LP | 13,920,000 | $12,909,000 | 0.50% |
| Maven Securities LTD | 14,280,000 | $14,280,000 | 0.46% |
| Saltoro Capital, LP | 1,350,000 | $1,252,000 | 0.44% |
| Baupost Group | 30,000,000 | $27,640,000 | 0.25% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $5,182,000 | 0.12% |
| ZAZOVE ASSOCIATES LLC | 1,250,000 | $1,163,000 | 0.10% |
| HBK INVESTMENTS L P | 22,500,000 | $20,832,000 | 0.08% |